Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of genomic variants on patient response to inhaled bronchodilators: a comprehensive update.

Expert opinion on drug metabolism & toxicology - 1 Jan 2000

Matera Maria Gabriella, Rogliani Paola, Novelli Giuseppe, Cazzola Mario

Abstract excerpt

INTRODUCTION: The bronchodilator response (BDR) depends on many factors, including genetic ones. Numerous single nucleotide polymorphisms (SNPs) influencing BDR have been identified. However, despite several studies in this field, genetic variations are not currently being utilized to support the use of bronchodilators. AREAS COVERED: In this narrative review, the possible impact of genetic variants on BDR is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Albuterol
Share to Bronchodilator Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genomics

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Share to Receptors, Adrenergic, beta-2

Source

Identifiers

PMID: 37269324
DOI: 10.1080/17425255.2023.2221848

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of genomic variants on patient response to inhaled bronchodilators: a comprehensive update.PMID 37269324Read ↗

Do genetic polymorphisms alter patient response to inhaled bronchodilators?Semantic proximity Read ↗

Clinical consequences of ADRbeta2 polymorphisms.Semantic proximity Read ↗

Treatment response heterogeneity in asthma: the role of genetic variation.Semantic proximity Read ↗

Pharmacogenetic and pharmacogenomic considerations of asthma treatment.Semantic proximity Read ↗

Development and Validation of Real-Time Allele-Specific PCR-Based Genotyping of the rs1042713 Variant in the ADRB2 Gene and Its Correlation with Salbutamol Response.Semantic proximity Read ↗

Pharmacogenetics of chronic obstructive pulmonary disease.Semantic proximity Read ↗

Asthma Pharmacogenomics: 2015 Update.Semantic proximity Read ↗

Pharmacogenetics of β2-AgonistsSemantic proximity Read ↗

Genetic variation of the beta(2)-adrenoceptor: its functional and clinical importance in bronchial asthma.Semantic proximity Read ↗

Pharmacogenetics of the beta 2-adrenergic receptor gene.Semantic proximity Read ↗

Pharmacogenetics of chronic obstructive pulmonary disease: challenges and opportunities.Semantic proximity Read ↗

Beta2-adrenoceptor polymorphisms and obstructive airway diseases: important issues of study design.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.